Synthesis Issue 3
The month in life sciences and intellectual property
Welcome to Synthesis, a regular publication offering our perspective on the latest developments in life sciences and intellectual property.
From the lab to the marketplace, DLA Piper understands today's complex business and regulatory environments. Working at the intersection of life sciences and IP, we bring together our real-world legal and regulatory experience and our deep knowledge of the science to protect your interests whenever and wherever you need help.
Please enjoy these articles, and if you have any questions about the implications of these issues for your business, please reach out to the authors, to our leaders – Lisa LeCointe-Cephas, Sean Cunningham, Gina Durham, Andrew Gilbert, and Matthew Holian – or to our editors, Susan Krumplitsch, Ellen Scordino, and Stephanie Piper.
